Combined use of neostigmine and ocular motility measurements in the diagnosis of myasthenia gravis.
Forty-four patients with diplopia caused by myasthenia gravis, ocular myopathies, and ocular motor nerve palsies underwent complete orthoptic evaluations before and after intramuscular injection of neostigmine (Prostigmin) methylsulfate. A test score combining the results of binocular and uniocular measurements was developed that allowed correct correct classification of 70% (31) of patients studied.
D003937:Diagnosis, Differential; D004172:Diplopia / Q000209:etiology; D005133:Eye Movements / Q000187:drug effects; D006801:Humans; D009157:Myasthenia Gravis / Q000150:complications / Q000175:diagnosis*; D009388:Neostigmine / Q000494:pharmacology; D009886:Ophthalmoplegia / Q000175:diagnosis
D009388:Neostigmine